268P Activating immune engagement against pancreatic ductal adenocarcinoma (PDAC): Effect of LSTA-1 and durvalumab on tumour-infiltrating lymphocytes (TILs).
Saved in:
| Title: | 268P Activating immune engagement against pancreatic ductal adenocarcinoma (PDAC): Effect of LSTA-1 and durvalumab on tumour-infiltrating lymphocytes (TILs). |
|---|---|
| Authors: | Talbot, A.1 (AUTHOR), Dean, A.2 (AUTHOR), Johannson, M.3 (AUTHOR), Yusoff, I.4 (AUTHOR), Rao, S.4 (AUTHOR), Sparrow, S.5 (AUTHOR), Kumarasinghe, P.5 (AUTHOR), Grew, J.6 (AUTHOR), Watanabe, Y.7 (AUTHOR), Robinson, M.8 (AUTHOR), Comito, O.R.9 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 1, Vol. 36, pS106-S106. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.05.283 |
